<DOC>
	<DOCNO>NCT00464802</DOCNO>
	<brief_summary>The primary objective determine safety tolerability new IV formulation versus current formulation MOA-728 focus theoretical potential infusion-related formulation-related complication .</brief_summary>
	<brief_title>Study Evaluating Safety Tolerability New Intravenous Formulation MOA-728 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>A sign date informed consent form . Men nonlactating nonpregnant woman , age 18 80 year , inclusive . Women nonchildbearing potential ( WONCBP ) must surgically sterile ( hysterectomy , oophorectomy , and/or tubal ligation ) postmenopausal ³1 year . Women childbearing potential ( WOCBP ) must use acceptable nonhormonal method contraception ( intrauterine device [ IUD ] , diaphragm , condom spermicidal jelly foam , abstinence ) period least 1 month dose administration . All woman must negative pregnancy test result within 48 hour start first test article administration . Body mass index range 18 32 kg/m² body weight ≥50 kg . Healthy determine investigator basis medical history , physical examination , clinical laboratory test result , vital sign , 12lead electrocardiogram ( ECG ) . Subjects age 65 80 year healthy , may enrol chronic illness , illness well control interfere primary objective study . Certain concomitant medication allow treatment condition list Concomitant Treatment section . Nonsmoker smoker few 10 cigarette per day determine history . Must able abstain smoke 48 hour throughout inpatient stay . Have high probability compliance completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>healthy</keyword>
	<keyword>safety</keyword>
</DOC>